TCL Archive In Brief: DCPC Still Looking For Yates’ Replacement New jersey Commission Offers New Fellowships December 4, 1987
TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
TCL Archive After Congressional Inquiry, NCI Posts Ambiguous Statement On Abortion And Breast Cancer Risk December 13, 2002
